The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research

Am J Respir Crit Care Med. 2023 Sep 1;208(5):515-516. doi: 10.1164/rccm.202307-1174ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Control Groups
  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Pyridones

Substances

  • Pyridones